Kind Inc. — Plus Bar
by KIND Inc.MRT 176 Panel Triggers Identified
Clinical Product Assessment
Kind Inc. manufactures this product, which has been analyzed against the full MRT 176 panel — comprising 149 foods and 27 chemical additives — to identify potential immune-mediated sensitivities.
MRT Safety Assessment
This product contains 10 MRT-tested substances, including several primary allergens like peanuts, soy, and dairy, as well as almond and various sweeteners. The presence of multiple triggers across different food groups and chemical additives makes this product highly reactive for individuals on the LEAP protocol. It is classified as High Risk and is only appropriate for Phase 3 under the guidance of a practitioner.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 10
- Safe Ingredients: 4
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| peanuts | Peanut | Direct Match |
| almonds | Almond | Direct Match |
| honey | Honey | Direct Match |
| sugar | Cane Sugar | Direct Match |
| soy protein isolate | Soybean | Direct Match |
| cocoa powder | Cocoa | Direct Match |
| peanut butter | Peanut | Direct Match |
| tapioca starch | Tapioca | Direct Match |
| vanilla | Vanilla | Direct Match |
| whole milk | Cow’s Milk | Direct Match |
| soy lecithin | Lecithin (Soy) | Chemical Match |
| soy lecithin | Soybean | Direct Match |
LEAP Protocol Guidance
With 10 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist.
UPC Code: 602652186646
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Tree nut tested individually on the MRT panel. Almond flour and almond milk are common substitutes in elimination diets — verify your personal MRT results before using.
Cane sugar sensitivity is specific to sugarcane-derived sweeteners and is distinct from glucose intolerance. Look for it in ingredient lists as sucrose, cane juice, or turbinado sugar.
Cocoa (Theobroma cacao) is tested as a standalone substance. Reactivity to cocoa affects all chocolate-containing products. Distinct from dairy or sugar reactions that often co-occur in chocolate.
One of the most commonly reactive substances on the MRT panel. Found in dairy products and many processed foods as whey, casein, or milk solids. Cross-reactive with goat and sheep milk in some patients.
Honey is tested as a distinct substance on the MRT panel. It contains proteins that can trigger mediator release independently of its sugar content. Found in many "natural" sweetened products.
Soy lecithin is one of the most ubiquitous food additives, used as an emulsifier in chocolate, baked goods, and margarine. Even small amounts can trigger mediator release in sensitive patients.
Peanut is a legume (not a tree nut) tested on the MRT panel. Peanut oil, peanut butter, and peanut flour are all included. Distinct from IgE peanut allergy testing.
Soy-derived ingredients appear in a wide range of processed foods including soy lecithin, soybean oil, and textured soy protein. One of the most prevalent hidden triggers.
Tapioca (cassava-derived starch) is MRT-tested. Increasingly used as a gluten-free thickener, in boba tea, puddings, and as modified food starch. Common in allergen-free baking.
Vanilla extract and vanillin (synthetic vanilla) are both MRT-tested. Vanilla appears in baked goods, desserts, and flavored beverages. Check for "natural flavors" which may contain vanilla.
What This Means For Your Diet
With 10 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 10 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
More from KIND Inc.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners